{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:37:03Z","timestamp":1786700223316,"version":"build-2736575974"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although trastuzumab (TZB) significantly increases survival in patients with human epidermal growth factor receptor 2 (HER2\/ErbB2)-positive breast and gastrointestinal cancers, its use may be limited by chronic cardiotoxicity. Several tryptophan (Trp) metabolites are associated with oxidative stress, inflammation, and metabolic disturbances in heart failure (HF). Here, we aimed to characterize changes in left ventricular (LV) concentrations of selected Trp metabolites in a rat model of TZB-induced chronic cardiotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Male and female Wistar-Hannover rats (300\u2013400\u00a0g) were divided into 2-2 groups: i) physiological saline-treated (6 \u00d7 1 mL\/kg, i.p.) control, and ii) TZB-treated (2\u00a0mg\/kg, then 5 \u00d7 1 mg\/kg, i.p.) groups. At weeks 12 and 19, echocardiography was performed. At week 20, blood and LV samples were collected. Then, histology, RT-qPCR, and UHPLC-MS\/MS analyses of genes and metabolites related to nitro-oxidative stress, inflammation, glucose and fatty acid metabolism, and Trp metabolism were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Diastolic dysfunction began in both TZB-treated groups by week 12. At the endpoint, both TZB-treated groups showed echocardiographic, histologic, and molecular signs of chronic cardiotoxicity, accompanied by LV overexpression of genes associated with inflammation and nitro-oxidative stress, repression of glucose transporter 4, glycerol-3-phosphate dehydrogenase, and carnitine palmitoyltransferase. However, only female TZB-treated rats showed increased LV levels of Trp, 3-hydroxykynurenine, quinolinic acid, and nicotinamide adenine dinucleotide (NAD\n                      <jats:sup>+<\/jats:sup>\n                      ). In contrast, TZB-treated males presented lower LV levels of kynurenine and xanthurenic acid.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Comparable TZB-induced chronic cardiotoxicity developed in both sexes. However, LV Trp metabolite concentrations showed sex-divergent alterations, the significance of which should be clarified in further mechanistic studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1809964","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:36:16Z","timestamp":1782448576000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of potential sex-based differences in trastuzumab-induced chronic cardiotoxicity in a rat model"],"prefix":"10.3389","volume":"17","author":[{"given":"R\u00e9ka","family":"Losonczi","sequence":"first","affiliation":[{"name":"Cardiovascular Research Group, Department of Pathophysiology, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]},{"name":"Department of Biochemistry, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Galla","sequence":"additional","affiliation":[{"name":"Metabolic and Newborn Screening Laboratory, Department of Pediatrics, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merse","family":"Kis","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Group, Department of Pathophysiology, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]},{"name":"Department of Biochemistry, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Kupecz","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Group, Department of Pathophysiology, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]},{"name":"Department of Biochemistry, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1vid","family":"Volford","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Group, Department of Pathophysiology, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]},{"name":"Department of Biochemistry, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Siska","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9ka","family":"Somogyi","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Group, Department of Pathophysiology, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]},{"name":"Department of Biochemistry, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"F\u00f6ldesi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Cserni","sequence":"additional","affiliation":[{"name":"Department of Pathology, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Kriston","sequence":"additional","affiliation":[{"name":"Synthetic and Systems Biology Unit, HUN-REN Biological Research Centre","place":["Szeged, Hungary"]},{"name":"Single-Cell Technologies Ltd.","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Kov\u00e1cs","sequence":"additional","affiliation":[{"name":"Synthetic and Systems Biology Unit, HUN-REN Biological Research Centre","place":["Szeged, Hungary"]},{"name":"Single-Cell Technologies Ltd.","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"Synthetic and Systems Biology Unit, HUN-REN Biological Research Centre","place":["Szeged, Hungary"]},{"name":"Single-Cell Technologies Ltd.","place":["Szeged, Hungary"]},{"name":"Institute for Molecular Medicine Finland, University of Helsinki","place":["Helsinki, Finland"]},{"name":"Institute of AI for Health, Helmholtz Zentrum M\u00fcnchen","place":["Neuherberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Monostori","sequence":"additional","affiliation":[{"name":"Metabolic and Newborn Screening Laboratory, Department of Pediatrics, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Kah\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Oncotherapy, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"S\u00e1rk\u00f6zy","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Group, Department of Pathophysiology, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]},{"name":"Department of Biochemistry, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1161\/circulationaha.121.056589","article-title":"NAD+ metabolism in cardiac health, aging, and disease","volume":"144","author":"Abdellatif","year":"2021","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejcsup.2014.03.002","article-title":"Cardiovascular disease after cancer therapy","volume":"12","author":"Aleman","year":"2014","journal-title":"EJC Suppl."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/CIRCULATIONAHA.106.612325","article-title":"5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling","volume":"114","author":"Antoniades","year":"2006","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"166618","DOI":"10.1016\/j.bbadis.2022.166618","article-title":"Melatonin and metformin ameliorated trastuzumab-induced cardiotoxicity through the modulation of mitochondrial function and dynamics without reducing its anticancer efficacy","volume":"1869","author":"Arinno","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/MCG.0b013e3182557307","article-title":"Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer","volume":"46","author":"Bang","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41401-024-01397-3","article-title":"A recombinant fragment antigen-binding (Fab) of trastuzumab displays low cytotoxic profile in adult human cardiomyocytes: first evidence and the key implication of Fc\u03b3RIIA receptor","volume":"46","author":"Bartolo","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1089\/ars.2013.5566","article-title":"Tetrahydrobiopterin in cardiovascular health and disease","volume":"20","author":"Bendall","year":"2014","journal-title":"Antioxid. Redox Signal"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1038\/s41388-021-01719-3","article-title":"Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts","volume":"40","author":"Berdiel-Acer","year":"2021","journal-title":"Oncogene"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/jnci\/djs317","article-title":"Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study","volume":"104","author":"Bowles","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"B10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B11","doi-asserted-by":"publisher","first-page":"110841","DOI":"10.1016\/j.exger.2020.110841","article-title":"Kynurenine pathway, NAD+ synthesis, and mitochondrial function: targeting tryptophan metabolism to promote longevity and healthspan","volume":"132","author":"Castro-Portuguez","year":"2020","journal-title":"Exp. Gerontol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"a040550","DOI":"10.1101\/cshperspect.a040550","article-title":"NADPH-the forgotten reducing equivalent","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/ijms23010441","article-title":"Cancer therapy-induced Cardiotoxicity-A metabolic perspective on pathogenesis, diagnosis and therapy","volume":"23","author":"Choksey","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/ncomms2236","article-title":"Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism","volume":"3","author":"Ding","year":"2012","journal-title":"Nat. Commun."},{"key":"B15","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1470-2045(21)00288-6","article-title":"Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials","volume":"22","year":"2021","journal-title":"Lancet Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40959-023-00172-3","article-title":"Mechanisms of trastuzumab induced cardiotoxicity - is exercise a potential treatment?","volume":"9","author":"Eaton","year":"2023","journal-title":"Cardiooncology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.breast.2018.03.006","article-title":"HER2-positive breast cancer: current and new therapeutic strategies","volume":"39","author":"Escriv\u00e1-de-Roman\u00ed","year":"2018","journal-title":"Breast"},{"key":"B18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10549-012-2103-8","article-title":"Mechanisms of cardiotoxicity associated with ErbB2 inhibitors","volume":"134","author":"Fedele","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"B19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","article-title":"Cardiovascular disease risk among cancer survivors: the atherosclerosis risk in communities (ARIC) study","volume":"80","author":"Florido","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"122846","DOI":"10.1016\/j.jchromb.2021.122846","article-title":"Improved LC-MS\/MS method for the determination of 42 neurologically and metabolically important molecules in urine","volume":"1179","author":"Galla","year":"","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"461775","DOI":"10.1016\/j.chroma.2020.461775","article-title":"Simultaneous determination of 30 neurologically and metabolically important molecules: a sensitive and selective way to measure tyrosine and tryptophan pathway metabolites and other biomarkers in human serum and cerebrospinal fluid","volume":"1635","author":"Galla","year":"","journal-title":"J. Chromatogr. A"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1074\/jbc.M804570200","article-title":"Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways","volume":"284","author":"Gordon","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"6933","DOI":"10.3390\/ijms25136933","article-title":"Kynurenic Acid\/AhR signaling at the junction of inflammation and cardiovascular diseases","volume":"25","author":"Grishanova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"619622","DOI":"10.3389\/fonc.2020.619622","article-title":"Increased risk of cardiovascular death in breast cancer patients without chemotherapy or (and) radiotherapy: a large population-based study","volume":"10","author":"Guan","year":"2020","journal-title":"Front. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"796223","DOI":"10.3389\/fonc.2021.796223","article-title":"Case report: collapsing focal segmental glomerulosclerosis after initiation of ado-trastuzumab emtansine therapy","volume":"11","author":"Hakroush","year":"2021","journal-title":"Front. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"112763","DOI":"10.1016\/j.celrep.2023.112763","article-title":"Kynurenine monooxygenase regulates inflammation during critical illness and recovery in experimental acute pancreatitis","volume":"42","author":"Hayes","year":"2023","journal-title":"Cell. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.111.075978","article-title":"Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity","volume":"126","author":"He","year":"2012","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/jpm13050750","article-title":"Trastuzumab-mediated cardiotoxicity and its preventive intervention by zingerone through antioxidant and inflammatory pathway in rats","volume":"13","author":"Khan","year":"2023","journal-title":"J. Pers. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.118.037357","article-title":"Human-induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in patients with breast cancer","volume":"139","author":"Kitani","year":"2019","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12963","DOI":"10.3390\/ijms222312963","article-title":"Investigation of the antihypertrophic and antifibrotic effects of losartan in a rat model of radiation-induced heart disease","volume":"22","author":"Kov\u00e1cs","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"107159","DOI":"10.1016\/j.carpath.2019.107159","article-title":"Early morphological changes in cardiac mitochondria after subcutaneous administration of trastuzumab in rabbits: possible prevention with oral selenium supplementation","volume":"44","author":"Laird-Fick","year":"2020","journal-title":"Cardiovasc Pathol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1172\/JCI14172","article-title":"Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension","volume":"111","author":"Landmesser","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10549-021-06427-w","article-title":"Trastuzumab does not bind rat or mouse ErbB2\/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics","volume":"191","author":"Lewis Phillips","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"B34","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1161\/CIRCULATIONAHA.107.690487","article-title":"Role of neuregulin-1\/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure","volume":"116","author":"Lemmens","year":"2007","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"821663","DOI":"10.3389\/fcvm.2021.821663","article-title":"The research progress of trastuzumab-induced cardiotoxicity in HER-2-Positive breast cancer treatment","volume":"8","author":"Lin","year":"2021","journal-title":"Front. Cardiovasc Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.niox.2016.02.006","article-title":"Effect of asymmetric dimethylarginine (ADMA) on heart failure development","volume":"54","author":"Liu","year":"2016","journal-title":"Nitric Oxide"},{"key":"B37","doi-asserted-by":"publisher","first-page":"104741","DOI":"10.1016\/j.breast.2026.104741","article-title":"Focusing on toxicity management: challenges and strategies for HER2-targeted antibody-drug conjugates in breast cancer","volume":"86","author":"Liu","year":"2026","journal-title":"Breast"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0227365","DOI":"10.1371\/journal.pone.0227365","article-title":"Plasma kynurenines and prognosis in patients with heart failure","volume":"15","author":"Lund","year":"2020","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.2174\/0929867321666140304105526","article-title":"Disturbed tryptophan metabolism in cardiovascular disease","volume":"21","author":"Mangge","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11739-015-1362-x","article-title":"Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer","volume":"11","author":"Mantarro","year":"2016","journal-title":"Intern Emerg. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"9904","DOI":"10.3390\/ijms22189904","article-title":"Tryptophan: from diet to cardiovascular diseases","volume":"22","author":"Melhem","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e71031","DOI":"10.1002\/hsr2.71031","article-title":"Left ventricular function and echocardiographic parameters in patients undergoing chemotherapy with 5-Fluorouracil, anthracycline, taxotere, and herceptin: prospective cohort study","volume":"8","author":"Moghadam","year":"2025","journal-title":"Health Sci. Rep."},{"key":"B43","article-title":"Implications of autophagy and oxidative stress in trastuzumab-mediated cardiac toxicities","volume":"2","author":"Mohan","year":"2017","journal-title":"Austin Pharmacol. Pharm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/abt\/tby003","article-title":"Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers","volume":"1","author":"Mohan","year":"2018","journal-title":"Antib. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1758835919894105","DOI":"10.1177\/1758835919894105","article-title":"Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer","volume":"11","author":"Montagna","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"120656","DOI":"10.1016\/j.lfs.2022.120656","article-title":"Could allicin alleviate trastuzumab-induced cardiotoxicity in a rat model through antioxidant, anti-inflammatory, and antihyperlipidemic properties?","volume":"302","author":"Mousa","year":"2022","journal-title":"Life Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12609-023-00516-z","article-title":"Impact of systemic therapy on fertility in women with early-stage breast cancer","volume":"16","author":"Natsuhara","year":"2024","journal-title":"Curr. Breast Cancer Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40169-016-0133-2","article-title":"The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes","volume":"6","author":"Necela","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/01.coc.0000190274.00570.0a","article-title":"Trastuzumab and antiestrogen therapy: focus on mechanisms of action and resistance","volume":"29","author":"Oca\u00f1a","year":"2006","journal-title":"Am. J. Clin. Oncol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153668","article-title":"Asymmetric (ADMA) and symmetric (SDMA) dimethylarginines in chronic kidney disease: a clinical approach","volume":"20","author":"Oliva-Damaso","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"6010","DOI":"10.3390\/ijms24066010","article-title":"Sex differences in tryptophan metabolism: a systematic review focused on neuropsychiatric disorders","volume":"24","author":"Pais","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.addr.2006.05.003","article-title":"Application and potential limitations of animal models utilized in the development of trastuzumab (herceptin): a case study","volume":"58","author":"Pegram","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41523-023-00533-2","article-title":"Estrogen\/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive\/HER2-positive breast cancer","volume":"9","author":"Pegram","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.yexcr.2007.02.007","article-title":"Inhibition of ErbB2\/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes","volume":"313","author":"Pentassuglia","year":"2007","journal-title":"Exp. Cell. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"807271","DOI":"10.3389\/fimmu.2022.807271","article-title":"Targeting tryptophan catabolism in cancer immunotherapy era: challenges and perspectives","volume":"13","author":"Peyraud","year":"2022","journal-title":"Front. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/biomedicines11030945","article-title":"The tryptophan-kynurenine metabolic system is suppressed in cuprizone-induced model of demyelination simulating progressive multiple sclerosis","volume":"11","author":"Poly\u00e1k","year":"2023","journal-title":"Biomedicines"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1096\/fj.09-131383","article-title":"Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents","volume":"23","author":"Riccio","year":"2009","journal-title":"FASEB J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tips.2015.03.005","article-title":"Anthracyclines\/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms","volume":"36","author":"Rochette","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/omi.2024.0004","article-title":"What powers trastuzumab\u2019s cardiotoxicity? Decoding mitochondrial-related gene expression through integrative review and meta-analysis in cardiomyocytes","volume":"28","author":"Rodrigues","year":"2024","journal-title":"OMICS"},{"key":"B60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13293-021-00392-1","article-title":"Ischemic preconditioning protects the heart against ischemia-reperfusion injury in chronic kidney disease in both males and females","volume":"12","author":"S\u00e1rk\u00f6zy","year":"2021","journal-title":"Biol. Sex. Differ."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.jacbts.2023.03.003","article-title":"Neuregulin-1\u03b2 improves uremic cardiomyopathy and renal dysfunction in rats","volume":"8","author":"S\u00e1rk\u00f6zy","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"330","DOI":"10.14740\/cr1700","article-title":"The role of inducible nitric oxide synthase in assessing the functional level of coronary artery lesions in chronic coronary syndrome","volume":"15","author":"Senderovic","year":"2024","journal-title":"Cardiol. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"106934","DOI":"10.1016\/j.phrs.2023.106934","article-title":"Ferritin nanoconjugates guide trastuzumab brain delivery to promote an antitumor response in murine HER2 + breast cancer brain metastasis","volume":"196","author":"Sevieri","year":"2023","journal-title":"Pharmacol. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e70124","DOI":"10.1002\/jcla.70124","article-title":"Integrated transcriptomic and metabolomic analysis revealed that tryptophan metabolism-related metabolites are biomarkers of trastuzumab resistance","volume":"39","author":"Si","year":"2025","journal-title":"J. Clin. Lab. Anal."},{"key":"B65","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bbrc.2011.06.169","article-title":"Herceptin, a recombinant humanized anti-ERBB2 monoclonal antibody, induces cardiomyocyte death","volume":"411","author":"Singh","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3390\/jcdd10120489","article-title":"HER2-Targeted therapy-from pathophysiology to clinical manifestation: a narrative review","volume":"10","author":"Slavcheva","year":"2023","journal-title":"J. Cardiovasc Dev. Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/cvr\/cvae231","article-title":"Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond","volume":"120","author":"Sun","year":"2024","journal-title":"Cardiovasc Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3322\/caac.21705","article-title":"Antibody-drug conjugates: smart chemotherapy delivery across tumor histologies","volume":"72","author":"Tarantino","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1200\/JCO.2007.11.0106","article-title":"Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility","volume":"25","author":"Telli","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ctrv.2014.12.005","article-title":"Triple positive breast cancer: a distinct subtype?","volume":"41","author":"Vici","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"B71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.yjmcc.2024.07.008","article-title":"NAD metabolism and heart failure: mechanisms and therapeutic potentials","volume":"195","author":"Walker","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"122541","DOI":"10.1016\/j.lfs.2024.122541","article-title":"ATM deficiency differentially affects expression of proteins related to fatty acid oxidation and oxidative stress in a sex-specific manner in response to western-type diet prior to and following myocardial infarction","volume":"342","author":"Wang-Heaton","year":"2024","journal-title":"Life Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"369","DOI":"10.7150\/ijms.89370","article-title":"NAD+-A hub of energy metabolism in heart failure","volume":"21","author":"Wu","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"B75","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10555-015-9552-6","article-title":"HER2 expression status in diverse cancers: review of results from 37,992 patients","volume":"34","author":"Yan","year":"2015","journal-title":"Cancer Metastasis Rev."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1406856","DOI":"10.3389\/fcvm.2024.1406856","article-title":"The role of the kynurenine pathway in cardiovascular disease","volume":"11","author":"Yang","year":"2024","journal-title":"Front. Cardiovasc Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2023.06.019","article-title":"Trastuzumab-induced cardiomyopathy via ferroptosis-mediated mitochondrial dysfunction","volume":"206","author":"Ye","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13045-019-0737-2","article-title":"Progress and challenges in HER2-positive gastroesophageal adenocarcinoma","volume":"12","author":"Zhao","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1459151","DOI":"10.3389\/fcvm.2025.1459151","article-title":"Risk analysis of cardiovascular mortality after gastric cancer diagnosis: a large population-based study","volume":"12","author":"Zhao","year":"2025","journal-title":"Front. Cardiovasc Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"114024","DOI":"10.1016\/j.biopha.2022.114024","article-title":"Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3\/CPT1 pathway","volume":"157","author":"Zheng","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B81","doi-asserted-by":"publisher","first-page":"111087","DOI":"10.1016\/j.ygeno.2025.111087","article-title":"Exploring the mechanism of action of trastuzumab-induced cardiomyocyte atrophy based on the FN1\/PI3K\/AKT-mediated mTOR-independent signaling pathway","volume":"117","author":"Zhu","year":"2025","journal-title":"Genomics"},{"key":"B82","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1172\/JCI14442","article-title":"Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite","volume":"109","author":"Zou","year":"2002","journal-title":"J. Clin. Invest."}],"updated-by":[{"DOI":"10.3389\/fphar.2026.1926577","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1809964\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:07:37Z","timestamp":1786698457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1809964\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":82,"alternative-id":["10.3389\/fphar.2026.1809964"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1809964","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"1809964"}}